Emily Chan
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Hepatology top 5%
- Co-authors
- Chris TranDerek S. WelsbieBarbara J. FuegerIngo K. MellinghoffJohannes CzerninCharles L. SawyersGeorge ThomasRobert A. Blake
- Topics
- Plant Molecular Biology Research (3 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)Pancreatic and Hepatic Oncology Research (2 papers)
- Cited by
- HepatologyAgingCancer Research
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Emily Chan
13 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Molecular Biology 1.0k
- Oncology 368
- Cancer Research 332
- Pulmonary and Respiratory Medicine 304
- Hepatology 250
Countries citing papers authored by Emily Chan
This map shows the geographic impact of Emily Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Chan more than expected).
Fields of papers citing papers by Emily Chan
This network shows the impact of papers produced by Emily Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Chan. The network helps show where Emily Chan may publish in the future.
Co-authorship network of co-authors of Emily Chan
This figure shows the co-authorship network connecting the top 25 collaborators of Emily Chan. A scholar is included among the top collaborators of Emily Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Chan. Emily Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 28 | |
| 3 | 23 | |
| 4 | 21 | |
| 5 | 12 | |
| 6 | 26 | |
| 7 | 43 | |
| 8 | 44 | |
| 9 | 256 | |
| 10 | 33 | |
| 11 | 57 | |
| 12 | Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancerbreakdown → | 507 |
| 13 | A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. | 421 |
About Emily Chan
Emily Chan is a scholar working on Aging, Endocrine and Autonomic Systems and Hepatology, having authored 13 papers that have together received 1.5k indexed citations. Recurring topics across this work include Plant Molecular Biology Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Hepatology (250 citations), Aging (48 citations) and Cancer Research (332 citations). Emily Chan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Chris Tran, Derek S. Welsbie, Barbara J. Fueger, Ingo K. Mellinghoff, Johannes Czernin, Charles L. Sawyers, George Thomas, Robert A. Blake, Jeremy Nance and James G. Christensen. Their work appears in journals such as Nature Medicine, Cancer Research and Journal of Cell Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.